Gastrointestinal Society

Gastrointestinal Society The Gastrointestinal Society is the Canadian leader in providing trusted, evidence-based information on all areas of the gastrointestinal tract.

As the Canadian leader in providing trusted, evidence-based information on all areas of the gastrointestinal tract, the GI (Gastrointestinal) Society is committed to improving the lives of people with GI and liver conditions, supporting research, advocating for appropriate access to health care, and promoting gastrointestinal and liver health. The GI Society is a registered Canadian charity, number 817065352RR0001.

👻
10/09/2026

👻

10/08/2026
Join us on Thursday, October 22, 2026, in Toronto for an evening marking 50 years of meaningful influence and impact. Ex...
10/08/2026

Join us on Thursday, October 22, 2026, in Toronto for an evening marking 50 years of meaningful influence and impact. Explore the key concerns of Most Favoured Nation international policies with Canadian experts. Expect an inspiring celebration of this milestone anniversary, thoughtful education on international policy and influence, and opportunities to connect with others throughout the evening.
Tickets are on sale now!
👉 https://badgut.org/inside-affair/

😂
10/02/2026

😂

On World Metastatic Colorectal Cancer (mCRC) Day, we recognize everyone affected by metastatic colorectal cancer and con...
09/30/2026

On World Metastatic Colorectal Cancer (mCRC) Day, we recognize everyone affected by metastatic colorectal cancer and continue to advocate for equitable access to personalized cancer care.

Cancer treatment is changing. Biomarker testing helps doctors understand the unique characteristics of a person’s tumour and identify treatments that may be more suitable for their cancer.

For some people living with mCRC, biomarker testing can provide important information about treatment options, including targeted therapies, immunotherapies, and clinical trials. Everyone deserves the opportunity to benefit from advances in cancer care, regardless of where they live or receive treatment.


Fight Colorectal Cancer Colorectal Cancer Alliance

Have you or a loved one been diagnosed with early-stage colorectal cancer? Patient organizations are gathering input fro...
09/28/2026

Have you or a loved one been diagnosed with early-stage colorectal cancer?

Patient organizations are gathering input from patients with early-stage colorectal cancer to inform a funding review of Dostarlimab (Jemperli) and Atezolizumab (Tecentriq) — two therapies for early stage dMMR/ MSI-H colorectal cancer.

We are seeking patients and caregivers to complete a short, confidential survey about their experience with stage II or III colorectal cancer and its treatment.

You do not need to have received either therapy to complete the survey. Patients who later progressed to have metastatic disease are also eligible to participate.

Your experiences play a critical role in helping decision-makers better understand the real-world impact of cancer and its treatments.

If this applies to you or someone you care for, we encourage you to complete the survey and share your experience.
https://www.surveymonkey.com/r/DS28B5F

CCRAN Canadian Cancer Survivor Network

Address

231-3665 Kingsway
Vancouver, BC
V5R5W2

Opening Hours

Monday 9am - 4pm
Tuesday 9am - 4pm
Wednesday 9am - 4pm
Thursday 9am - 4pm
Friday 9am - 4pm

Telephone

+16048734876

Alerts

Be the first to know and let us send you an email when Gastrointestinal Society posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share